Abstract. Acinetobacter baumannii is an emerging human pathogen that causes hospital-acquired infections. The trend in increased antimicrobial resistance limits the choice of effective antimicrobial agents. The present study reports the resistance to Acinetobacter baumannii and analyzes the associations between antibiotic use and resistance rates at a general hospital between 2010 and 2014. A total of 1,861 isolates were obtained from clinical cultures, accounting for 10.33% of all detected bacteria (1,861/18,016). The strains were mainly from respiratory samples (1,628 isolates, 87.5%) and the intensive care unit (696 isolates, 37.4%). The resistance rates of Acinetobacter baumannii to the majority of antibiotics were >50%, particularly the resistance rate to cefoperazone/sulbactam increased from 47.37 in 2011 to 89.25% in 2014. However, the rates of imipenem and cilastatin sodium decreased from 81.03 to 69.44% due to the antibiotic policy. There were Pearson significant associations between the use of three antibiotics and resistance in Acinetobacter baumannii to this drug, piperacillin/tazobactam (r=0.976, P<0.01), gentamicin (r=0.870, P<0.01) and cefoxitin (r=0.741, P<0.05). Therefore, a combination of drugs should be adopted to treat Acinetobacter baumannii infections. Microbiology laboratory support and surveillance policies are essential to control the emergence of multidrug-resistance Acinetobacter baumannii.
Introduction
Acinetobacter baumannii is an emerging human pathogen that causes hospital-acquired infections (1) . Acinetobacter baumannii infection could lead to a variety of illnesses such as pneumonia, meningitis and endocarditis (2) . In recent years, the drug resistance rates of Acinetobacter baumannii are increasing quickly worldwide, particularly with the appearance of carbapenem-resistant Acinetobacter baumannii (3) . Certain outbreaks of drug-resistant Acinetobacter baumannii have been documented previously (4, 5) .
The trend in increased antimicrobial resistance limits the choice of effective antimicrobial agents. Multidrug-resistant Acinetobacter baumannii and pan-drug-resistant Acinetobacter baumannii have made numerous currently available antimicrobial drugs ineffective (2) . Although several new antimicrobial therapeutics, such as the generation of nitric acid-producing nanoparticles (6) , gallium maltolate treatment (7) and nanoemulsion (8) , have been reported, the therapeutic efficacy and safety for people requires further investigation.
Currently, it is generally recognized that drug resistance is an unavoidable consequence of misuse and overuse of antibiotics. However, antibiotic treatments are not always the same for the differences of medical cognition in different regions, which leads to an eventual regional difference of bacterial resistance (9) .
The purpose of the present study was to report the resistance to Acinetobacter baumannii, and analyze the association between antibiotic use and resistance rates at a general hospital in the east of China between 2010 and 2014.
Materials and methods
Bacterial isolates. The present study was performed at the Third People's Hospital, an 800-bed, tertiary-care teaching hospital affiliated with Southeast University (Yancheng, China). A total of 1,861 isolates were obtained from the clinical cultures between January 1, 2010 until December 31, 2014. Identification was performed using the VITEK 2 system (bioMerieux, Marcy l'Etoile, France) in the microbiological laboratory of the hospital.
Antimicrobial susceptibility. Antimicrobial susceptibility testing was performed using the disk diffusion method and susceptibility profiles were determined using zone diameter interpretive criteria, as recommended by the Clinical and Laboratory Standards Institute in 2011 (M100-S21 However, all of these rebounded in the first half of 2013, and subsequently decreased slowly thereafter.
Sulbactam is an irreversible inhibitor of β-lactamase, which is commonly used in the local hospital, and the increase of the resistance rates of cefoperazone/sulbactam was evident. There are three carbapenem antibiotics; imipenem, meropenem and biapenem. In 2011, the resistance rates of imipenem/cilastatin, meropenem and biapenem was almost 80%, and three years later, the resistance rates of meropenem and biapenem increased by 17%, but the resistance rates of imipenem/cilastatin decreased by 14%. Tigecycline was introduced in the hospital in 2013, and the resistance rate was <70%. Among a number of cephalosporin drugs, the third and the fourth generation cephalosporins, such as cefepime and ceftazidime, were active agents, but the other cephalosporins were not.
Association of hospital antibiotic use and resistance rate (%)
of Acinetobacter baumannii. The high level of antibiotic resistance was influenced by numerous factors; one of the most important factors was the overuse and misuse of antibiotics. Several antibiotic usage data were collected and were converted to DDDs, as shown in Table II . During the investigation period, the consumption of antibiotics varied from 192.60 to 25,412 DDDs. The usage of the second-generation cephalosporin drug ranked first, followed by quinolone, aminoglycoside and others. There were statistically significant associations between the uses of several antibiotics and resistance in Acinetobacter baumannii to the drug as shown in Table III . The gentamicin usage was significantly correlated with resistance in Acinetobacter baumannii to this drug (rs=0.870, P<0.01). Furthermore, the association between the use of various types of antibiotic and resistance rate (%) of Acinetobacter baumannii was analyzed, as shown in Table IV . There were statistically significant associations between the resistance rate of biapenem and usage of aminoglycosides (r=-0.924, P<0.01).
Discussion
The drug resistance data between 2010 and 2014 showed that the resistance rates of the majority of antimicrobial drugs was >70% in Acinetobacter baumannii. Thus, it became more difficult to cure Acinetobacter baumannii infection, and one more active agent is required based on the resistance experience. The antibiotic policy was introduced in the hospital in 2011, and the majority of antibiotics used were restricted and guided by rules. The policy promoted the rational use of antimicrobial drugs, and certain antimicrobial resistant rates periodically reduced. However, all the antibiotic resistance rates did not decrease at the same time to cure infection, and there was a fluctuation. These drops and fluctuations of the resistance rates of certain antibiotics were closely associated with the usage of antibiotics according to the statistical analysis, confirming that an antimicrobial susceptibility test is important in providing useful information for effective treatment, and occasionally more than one antibiotic is required to cure Acinetobacter baumannii infection. To decrease the spread of Acinetobacter baumannii infections, surveillance is also important to restrict the abuse of antibiotics and guide the rational usage of antibiotics. Table IV . Association between the use of various types of antibiotics and the resistance rates (%) of Acinetobacter baumannii. 
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